WNT5A and B-cell chronic lymphocytic leukemia: Strikingly, increased expression of Wnt5a and some other components of beta-catenin-independent signaling is associated with changes in chemotactic and migratory properties and is a predictor of clinical outcome in CLL (Kaucká et al., 2013; Janovska et al., 2016).